Argenica Therapeutics Limited (AGN.AX)
AUD 0.62
(-3.13%)
AUD 0.62
(-3.13%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 2.59 Million AUD | 48.46% |
| 2023 | 1.74 Million AUD | 575.38% |
| 2022 | 259.09 Thousand AUD | -12.49% |
| 2021 | 296.07 Thousand AUD | 0.0% |
| 2020 | - AUD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 122.75 Thousand AUD | -89.56% |
| 2024 Q4 | 122.75 Thousand AUD | 0.0% |
| 2024 FY | - AUD | -100.0% |
| 2024 Q2 | 1.17 Million AUD | 0.0% |
| 2024 Q1 | 1.17 Million AUD | 532.4% |
| 2023 Q2 | 688.95 Thousand AUD | -0.0% |
| 2023 FY | 1.74 Million AUD | 575.38% |
| 2023 Q4 | 185.99 Thousand AUD | 0.0% |
| 2023 Q3 | 185.99 Thousand AUD | -73.0% |
| 2023 Q1 | 688.95 Thousand AUD | 0.0% |
| 2022 FY | 259.09 Thousand AUD | -12.49% |
| 2022 Q3 | - AUD | -100.0% |
| 2022 Q2 | 129.54 Thousand AUD | 0.0% |
| 2022 Q1 | 129.54 Thousand AUD | 0.0% |
| 2022 Q4 | - AUD | 0.0% |
| 2021 FY | 296.07 Thousand AUD | 0.0% |
| 2021 Q2 | 148.03 Thousand AUD | -0.0% |
| 2021 Q4 | - AUD | 0.0% |
| 2021 Q1 | 148.03 Thousand AUD | 0.0% |
| 2021 Q3 | - AUD | -100.0% |
| 2020 Q2 | - AUD | 0.0% |
| 2020 FY | - AUD | 0.0% |
| 2020 Q4 | - AUD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 50.94 Million AUD | 94.901% |
| Anatara Lifesciences Ltd | -748.91 Thousand AUD | 446.896% |
| Zelira Therapeutics Limited | 10.28 Thousand AUD | -25161.931% |
| Biome Australia Limited | 7.66 Million AUD | 66.127% |
| Patrys Limited | 1.39 Million AUD | -86.344% |
| Orthocell Limited | 3.68 Million AUD | 29.565% |
| Imugene Limited | -5.83 Million AUD | 144.486% |
| Noxopharm Limited | -534.81 Thousand AUD | 585.767% |
| PYC Therapeutics Limited | 22.05 Million AUD | 88.223% |
| Chimeric Therapeutics Limited | 7.45 Million AUD | 65.146% |
| Prescient Therapeutics Limited | 3.71 Million AUD | 30.019% |
| Proteomics International Laboratories Limited | -1.12 Million AUD | 331.3% |
| Cynata Therapeutics Limited | 2.31 Million AUD | -12.191% |
| CSL Limited | 15.28 Billion AUD | 99.983% |
| Arovella Therapeutics Limited | -25.97 Thousand AUD | 10100.142% |
| Bio-Gene Technology Limited | -301.44 Thousand AUD | 961.816% |
| Clinuvel Pharmaceuticals Limited | 78.09 Million AUD | 96.673% |
| Starpharma Holdings Limited | 7.65 Million AUD | 66.071% |
| Nanollose Limited | -348.95 Thousand AUD | 844.497% |
| Memphasys Limited | 1606.00 AUD | -161664.446% |
| Invex Therapeutics Ltd | 1.21 Million AUD | -114.306% |
| NeuroScientific Biopharmaceuticals Limited | -91.33 Thousand AUD | 2944.342% |
| Amplia Therapeutics Limited | 4.01 Million AUD | 35.226% |
| Botanix Pharmaceuticals Limited | -6.55 Million AUD | 139.654% |
| Island Pharmaceuticals Limited | 1.25 Million AUD | -107.573% |
| Race Oncology Limited | 1.38 Million AUD | -86.913% |
| Nyrada Inc. | -5164.07 AUD | 50407.935% |
| Telix Pharmaceuticals Limited | 308.5 Million AUD | 99.158% |
| Dimerix Limited | 583.47 Thousand AUD | -345.25% |
| PharmAust Limited | -1641.00 AUD | 158414.26% |
| Immutep Limited | 1.44 Million AUD | -79.924% |
| Clarity Pharmaceuticals Ltd | 11.5 Million AUD | 77.422% |
| Alterity Therapeutics Limited | 3.8 Million AUD | 31.723% |
| BTC Health Limited | 16.36 Thousand AUD | -15779.811% |
| Acrux Limited | -1.28 Million AUD | 302.332% |
| Neuren Pharmaceuticals Limited | 205.17 Million AUD | 98.734% |
| Biotron Limited | -40.49 Thousand AUD | 6514.976% |
| Tissue Repair Ltd | 150.51 Thousand AUD | -1626.078% |
| AdAlta Limited | 1.5 Million AUD | -72.287% |
| Radiopharm Theranostics Limited | -21.3 Million AUD | 112.192% |
| Hexima Limited | - AUD | -Infinity% |
| AnteoTech Limited | 460.39 Thousand AUD | -464.282% |
| Paradigm Biopharmaceuticals Limited | 56.81 Thousand AUD | -4472.867% |
| Recce Pharmaceuticals Ltd | -366.76 Thousand AUD | 808.333% |
| Avecho Biotechnology Limited | -43.79 Thousand AUD | 6032.04% |
| Actinogen Medical Limited | 9.93 Million AUD | 73.841% |
| Immuron Limited | 3.33 Million AUD | 22.143% |